Humoral response to mRNA anti–COVID-19 vaccines BNT162b2 and mRNA-1273 in patients with chronic lymphocytic leukemia
暂无分享,去创建一个
R. Letestu | B. Drénou | M. Béné | X. Troussard | A. Delmer | K. Laribi | V. Leblond | C. Dartigeas | V. Lévy | A. Michallet | F. Cymbalista | C. Bagacean | D. Chaoui | C. Tomowiak | P. Genet | S. Brichler | L. Willems | A. Clavert | F. Merabet | D. Roos-Weil | C. Al-Nawakil | Nanthara Sritharan | R. Guièze | Christian Puppinck | Hugo Legendre | Stéphanie Malartre | N. Sritharan | H. Legendre
[1] H. Ditzel,et al. Antibody and T cell immune responses following mRNA COVID-19 vaccination in patients with cancer , 2021, Cancer Cell.
[2] S. Fafi-Kremer,et al. Antibody Response After a Third Dose of the mRNA-1273 SARS-CoV-2 Vaccine in Kidney Transplant Recipients With Minimal Serologic Response to 2 Doses. , 2021, JAMA.
[3] Patrick W. Johnson,et al. Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies , 2021, Cancer Cell.
[4] P. Moss,et al. Antibody responses after first and second Covid-19 vaccination in patients with chronic lymphocytic leukaemia , 2021, Blood Cancer Journal.
[5] G. Shefer,et al. Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia , 2021, Blood.
[6] J. Mascola,et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine , 2020, The New England journal of medicine.
[7] P. Dormitzer,et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine , 2020, The New England journal of medicine.
[8] G. Marti,et al. Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines , 2020, Blood.
[9] K. Walker. SARS-CoV-2 Vaccine , 2020, Global reproductive health.
[10] M. Gentile,et al. Response to the conjugate pneumococcal vaccine (PCV13) in patients with chronic lymphocytic leukemia (CLL) , 2020, Leukemia.
[11] I. Barr,et al. Ibrutinib may impair serological responses to influenza vaccination , 2017, Haematologica.
[12] A. Tierens,et al. Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatment. , 2011, Blood.